Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease-Reference-Cited by-同舟云学术

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease

Published:2005-01 Issue:9457 Volume:365 Page:410-412
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Nichols William C,Pankratz Nathan,Hernandez Dena,Paisán-Ruíz Coro,Jain Shushant,Halter Cheryl A,Michaels Veronika E,Reed Terry,Rudolph Alice,Shults Clifford W,Singleton Andrew,Foroud Tatiana

Publisher

Elsevier BV

Subject

General Medicine

Reference7 articles.

1. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European community concerted action on the epidemiology of Parkinson's disease;de Rijk;J Neurol Neurosurg Psychiatry,1997

2. Genetic clues to the pathogenesis of Parkinson's disease;Vila;Nat Med,2004

3. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease;Paisán-Ruíz;Neuron,2004

4. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology;Zimprich;Neuron,2004

5. Hernandez DG, Páizan-Ruíz C, McInerney-Leo A, et al. Clinical and PET evaluation of Parkinson disease caused by a LRRK2 mutation. Ann Neurol (in press).

Cited by 367 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic risk variants in New Yorkers of Puerto Rican and Dominican Republic heritage with Parkinson’s disease;npj Parkinson's Disease;2023-12-07

2. Cell autonomous role of leucine-rich repeat kinase in protection of dopaminergic neuron survival;2023-10-10

3. Unlocking the potential of PROTACs: A comprehensive review of protein degradation strategies in disease therapy;Bioorganic Chemistry;2023-10

4. LRRK2 G2019S and Parkinson’s disease: insight from Neuroinflammation;Postgraduate Medical Journal;2023-09-30

5. Recent advances of PROTACs technology in neurodegenerative diseases;Arabian Journal of Chemistry;2023-09